Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 12, 2019

SELL
$7.72 - $12.81 $4.69 Million - $7.79 Million
-607,868 Closed
0 $0
Q4 2018

Jan 17, 2019

SELL
$9.51 - $16.6 $34,473 - $60,175
-3,625 Reduced 0.59%
607,868 $6.98 Million
Q3 2018

Oct 18, 2018

BUY
$13.05 - $19.05 $57,811 - $84,391
4,430 Added 0.73%
611,493 $0
Q2 2018

Jul 12, 2018

BUY
$13.9 - $19.8 $2.87 Million - $4.09 Million
206,657 Added 51.61%
607,063 $0
Q1 2018

Apr 16, 2018

BUY
$16.7 - $26.35 $6.69 Million - $10.6 Million
400,406 New
400,406 $0

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $153M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.